Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5′ MLL sequences in chromosome 4

被引:26
作者
von Bergh, A
Gargallo, P
De Prijck, B
Vranckx, H
Marschalek, R
Larripa, I
Kluin, P
Schuuring, E
Hagemeijer, A
机构
[1] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium
[2] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RA Leiden, Netherlands
[3] Acad Nacl Med, Inst Invest Hematol, Dept Genet, Buenos Aires, DF, Argentina
[4] CHR Citadelle, Liege, Belgium
[5] Univ Erlangen Nuernberg, Dept Genet, Erlangen, Germany
关键词
acute lymphoblastic leukemia; MLL; AF4; cryptic translocation; FISH;
D O I
10.1038/sj.leu.2402050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The t(4;11) translocation is the cytogenetic hallmark of a subset of acute lymphoblastic leukemias characterized by pro-B immunophenotype and a dismal prognosis. This translocation fuses the MLL gene on chromosome band 11q23 and the AF4 gene on 4q21, resulting in the expression of fusion transcripts from both translocated chromosomes. The MLL-AF4 chimeric transcript is thought to mediate the leukemic transformation. The MLL genomic disruption detected by Southern blot and the RT-PCR for the MLL-AF4 chimeric transcript expression are molecular evidence of this chromosomal translocation. However, similar molecular rearrangements have also been identified in cases without the cytogenetic t(4;11). We report a 30-year-old patient with high risk ALL, a normal karyotype, and molecular evidence of MLL-AF4 fusion, Using a double color FISH assay with MLL specific PAC probes, a cryptic t(4;11) due to insertion of 5' MLL sequences in chromosome 4q21 was demonstrated. Consequently the MLL-AF4 was encoded by der(4). This insertion mechanism precludes the genomic recombination of AF4-MLL end supports the crucial role played by MLL-AF4 in leukemogenesis. The findings of our case, along with others, show the importance of complementing the karyotype with molecular and FISH techniques.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 32 条
[1]  
BIONDI A, 1993, BLOOD, V82, P2943
[2]  
CHEN CS, 1993, BLOOD, V81, P2386
[3]   Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL-1/AF-4 positive-acute lymphoblastic leukaemia [J].
Cimino, G ;
Elia, L ;
Rivolta, A ;
Rapanotti, MC ;
Rossi, V ;
Alimena, G ;
Annino, L ;
Canaani, E ;
LoCoco, F ;
Biondi, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (03) :659-664
[4]  
Dierlamm J, 1996, GENE CHROMOSOME CANC, V16, P261, DOI 10.1002/(SICI)1098-2264(199608)16:4<261::AID-GCC6>3.0.CO
[5]  
2-W
[6]   ACUTE MIXED-LINEAGE LEUKEMIA T(4-11)(Q21-Q23) GENERATES AN MLL-AF4 FUSION PRODUCT [J].
DOMER, PH ;
FAKHARZADEH, SS ;
CHEN, CS ;
JOCKEL, J ;
JOHANSEN, L ;
SILVERMAN, GA ;
KERSEY, JH ;
KORSMEYER, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7884-7888
[7]   THE DER(11)-ENCODED MLL/AF-4 FUSION TRANSCRIPT IS CONSISTENTLY DETECTED IN T(4 11)(Q21 Q23)-CONTAINING ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
DOWNING, JR ;
HEAD, DR ;
RAIMONDI, SC ;
CARROLL, AJ ;
CURCIOBRINT, AM ;
MOTRONI, TA ;
HULSHOF, MG ;
PULLEN, DJ ;
DOMER, PH .
BLOOD, 1994, 83 (02) :330-335
[8]   Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia [J].
Faderl, S ;
Kantarjian, HM ;
Talpaz, M ;
Estrov, Z .
BLOOD, 1998, 91 (11) :3995-4019
[9]  
GRIESINGER F, 1994, LEUKEMIA, V8, P542
[10]  
Grimwade D, 1997, BLOOD, V90, P4876